Using CaP wrapping can effectively shield and protect Ftn, when transported to the weak acid environment of the tumour, and thus release the drug after binding to CD71 into cancer cells, promoting tumour calcification and immune response.62 The gene discussed is TFRC; the disease is neoplasm.